Skip to content
DE
Peptide

TB-500

TB-500 is a synthetic peptide derived from thymosin beta-4, a small protein found in most human cells.

What it is studied for

The strongest rated effects first. Bars show the size of the effect, the letter grades the evidence, and each rating lists the studies behind it.

Immune responseImmune SupportNo effectFNo linked study
InflammationNo effectFNo linked study
Joint MobilityBone & JointNo effectFNo linked study
Muscle RecoveryFitnessNo effectFNo linked study
Endurance and staminaFitnessNo effectFNo linked study
Injury PreventionFitnessNo effectFNo linked study
Every rating with its studiesGrouped by health goal, with the publications behind each rating

Is TB-500 the same as thymosin beta-4?

FDA’s 2026 evaluation defines TB-500 as an acetylated seven-amino-acid fragment, Ac-LKKTETQ, rather than the full-length thymosin beta-4 molecule. The added acetyl group changes chemical properties, so even studies of the unmodified fragment require caution when applied to TB-500. 1

Questions people ask

Do mouse wound findings prove human recovery benefits?

No. They concern a non-acetylated fragment in aged mice, not a clinical test of TB-500. 1 2

Do thymosin eye-drop trials validate TB-500?

No. The molecule, formulation, route and treated condition differ. 1 3

Is a safe human regimen established?

The FDA safety assessment lacks human exposure information sufficient to establish safety. 4

Is it allowed outside competition?

No. The 2026 WADA prohibition applies at all times. 5

Sources